Nilsang Suthasinee, Nehru Vishal, Plieva Fatima M, Nandakumar Kutty Selva, Rakshit Sudip Kumar, Holmdahl Rikard, Mattiasson Bo, Kumar Ashok
Dept of Biotechnology, Center for Chemistry and Chemical Engineering, Lund University, Lund, Sweden.
Biotechnol Prog. 2008 Sep-Oct;24(5):1122-31. doi: 10.1002/btpr.28.
Cell proliferation and long-term production of monoclonal antibody IgG(2b) by M2139 hybridoma cells immobilized in macroporous gel particles (MGPs) in packed-bed reactor were studied for a period of 60 days. The MGPs were made of supermacroporous gels produced in frozen conditions from crosslinked polyacrylamide and modified with gelatin which were housed in special plastic carriers (7 x 9 mm(2)). Cells were trapped in the interior part of MGPs by attaching to the void space of the gel matrix as three-dimensional (3D) cultivation using gelatin as a substrate layer. Optimizing productivity by hybridoma cell relies on understanding regulation of antibody production. In this study, the behavior of M2139 cells in two-dimensional cultures on multiwell plate surfaces was also investigated. The effect of three different medium such as basal medium Dulbecco's modified Eagle's medium (D-MEM) containing L-glutamine or L-glutamine + 2 mM alpha-ketoglutarate or L-alanyl-glutamine (GlutaMAXtrade mark) was studied prior to its use in 3D cultivation. The kinetics of cell growth in basal medium containing L-glutamine + alpha-ketoglutarate was similar to cells grown on GlutaMAX containing medium, whereas D-MEM containing L-glutamine showed lower productivity. With the maximal viable cell density (6.85 x 10(6) cells mL(-1)) and highest specific mAb production rate (3.9 mug mL(-1) 10(-4) viable cell day(-1)), D-MEM-GlutaMAX was further selected for 3D cultivation. Cells in MGPs were able to grow and secrete antibody for 30 days in packed-bed batch reactor, before a fresh medium reservoir was replaced. After being supplied with fresh medium, cells again showed continuous growth for another 30 days with mAb production efficiency of 50%. These results demonstrate that MGPs can be used efficiently as supporting carrier for long-term monoclonal antibody production.
研究了在填充床反应器中固定于大孔凝胶颗粒(MGP)中的M2139杂交瘤细胞的细胞增殖及单克隆抗体IgG(2b)的长期生产情况,为期60天。MGP由在冷冻条件下由交联聚丙烯酰胺制成并经明胶修饰的超大孔凝胶制成,置于特殊塑料载体(7×9 mm(2))中。细胞通过附着在凝胶基质的空隙空间中,以明胶作为底物层进行三维(3D)培养,从而被困在MGP的内部。杂交瘤细胞优化生产力依赖于对抗体产生调控的理解。在本研究中,还研究了M2139细胞在多孔板表面二维培养中的行为。在将三种不同培养基(如含L-谷氨酰胺的基础培养基杜尔贝科改良伊格尔培养基(D-MEM)、含L-谷氨酰胺+2 mMα-酮戊二酸的培养基或L-丙氨酰-谷氨酰胺(GlutaMAX商标))用于3D培养之前,对其效果进行了研究。含L-谷氨酰胺+α-酮戊二酸的基础培养基中细胞生长动力学与在含GlutaMAX的培养基中生长的细胞相似,而含L-谷氨酰胺的D-MEM显示出较低的生产力。由于具有最大活细胞密度(6.85×10(6) 个细胞 mL(-1))和最高特异性单克隆抗体产生率(3.9 μg mL(-1) 10(-4) 个活细胞天(-1)),D-MEM-GlutaMAX被进一步选用于3D培养。在填充床分批反应器中,MGP中的细胞能够生长并分泌抗体30天,之后更换新鲜培养基储液器。在供应新鲜培养基后,细胞再次持续生长30天,单克隆抗体生产效率为50%。这些结果表明,MGP可有效地用作长期生产单克隆抗体的支持载体。